300406.SZ
九强生物
SZSE · Healthcare · C 制造业 · CN
CNY 11.51
−1.62%Margins
Gross margin
79.6%
EBITDA margin
22.4%
EBIT margin
19.1%
Net margin
15.5%
FCF margin
40.7%
5.5%
Return on equity
4.1%
Return on assets
6.7%
Return on invested capital
0.27x
Asset turnover
CNY 589.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026